United States Biotechnology & Medical Research

Emerald Bioscience Inc (EMBI)

Track

Emerald Bioscience Inc. experienced significant insider selling activity during August 2025. Andrew J. Schwab and 5AM Partners VII, LLC executed multiple divestments of company shares on August 21 and 22. These transactions represent the most recent market movements by corporate insiders, following a series of sales conducted by various executives throughout November 2024.
Ticker: EMBI Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
83.34
Quantity 48,267 +4.6%
Value US$381,157
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
121.72
Quantity 29,923 +47.0%
Value US$4,757,507
1.1
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
45.84
Quantity 31,156 -36.0%
Value US$4,064,132
1.1
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
3.42
Quantity 163,979 -10.1%
Value US$560,808
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
3.57
Quantity 2,314 -3.5%
Value US$8,261
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
3.57
Quantity 58,642 -3.5%
Value US$209,352
1.1
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
3.57
Quantity 2,314 -3.5%
Value US$8,261
1.1
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
3.57
Quantity 58,642 -3.5%
Value US$209,352
Diep Tuan Tu Chief Development Officer Officer
Transaction date
Sale
Price
4.99
Quantity 19,489 -19.2%
Value US$97,250
ARSENAULT KAITLYN Chief Financial Officer Officer
Transaction date
Sale
Price
4.99
Quantity 43,206 -20.6%
Value US$215,598
DHILLON PUNIT Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.99
Quantity 82,546 -20.0%
Value US$411,905
Grayson Paul A. Non-Executive Director
Transaction date
Sale
Price
4.99
Quantity 86,244 -24.9%
Value US$430,358
Diep Tuan Tu Chief Development Officer Officer
Transaction date
Sale
Price
5.55
Quantity 85 -0.1%
Value US$472
ARSENAULT KAITLYN Chief Financial Officer Officer
Transaction date
Sale
Price
5.55
Quantity 190 -0.1%
Value US$1,054
DHILLON PUNIT Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.55
Quantity 364 -0.1%
Value US$2,020
Grayson Paul A. Non-Executive Director
Transaction date
Sale
Price
5.55
Quantity 307 -0.1%
Value US$1,704
ARSENAULT KAITLYN Officer Officer
Transaction date
Proposed sale
Price
5.51
Quantity 57,084
Value US$314,533
DHILLON PUNIT Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.51
Quantity 100,693
Value US$554,818
Diep Tuan Tu Officer Officer
Transaction date
Proposed sale
Price
5.51
Quantity 22,877
Value US$126,052
Grayson Paul A. Director Non-Executive Director
Transaction date
Proposed sale
Price
5.51
Quantity 86,804
Value US$478,290
1.1
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.06
Quantity 79 -0.1%
Value US$479
1.1
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.06
Quantity 2,000 -0.1%
Value US$12,120
1.1
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.06
Quantity 11,758 -0.1%
Value US$71,253
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
6.06
Quantity 2,000 -0.1%
Value US$12,120
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
6.06
Quantity 11,758 -0.1%
Value US$71,253
1.1
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.60
Quantity 1,440 -2.1%
Value US$9,504
1.1
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.60
Quantity 36,504 -2.1%
Value US$240,926
1.1
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.60
Quantity 214,556 -2.6%
Value US$1,416,070
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
6.60
Quantity 1,440 -2.1%
Value US$9,504
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
6.60
Quantity 36,504 -2.1%
Value US$240,926
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
6.60
Quantity 214,556 -2.6%
Value US$1,416,070
5AM Partners VII, LLC Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 450,000 +5.7%
Value US$4,500,000
5AM Partners VII, LLC Large shareholder
Transaction date
Purchase
Price
2.31
Quantity 5,206,074 +190.2%
Value US$12,026,031
DHILLON PUNIT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.02
Quantity 881,000 +2.2%
Value US$16,475
Emerald Health Sciences Inc. Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 15,000,000
Value US$0
Ladin Brian D Large shareholder
Transaction date
Sale
Price
4.93
Quantity 11,830 -4.5%
Value US$58,310
Ladin Brian D Large shareholder
Transaction date
Sale
Price
4.79
Quantity 15,800 -5.7%
Value US$75,682
Ladin Brian D Large shareholder
Transaction date
Sale
Price
4.69
Quantity 23,000 -7.7%
Value US$107,893
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-22 2025-08-22 S Sale
5AM Partners VII, LLC
Large shareholder
48,267 +4.6%
83.34
US$381,157 		48,267 +4.6% 83.34 US$381,157
2025-08-22 2025-08-22 S Sale
5AM Partners VII, LLC
Large shareholder
29,923 +47.0%
121.72
US$4,757,507 		29,923 +47.0% 121.72 US$4,757,507
2025-08-22 2025-08-22 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
31,156 -36.0%
45.84
US$4,064,132 		31,156 -36.0% 45.84 US$4,064,132
2025-08-22 2025-08-22 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
163,979 -10.1%
3.42
US$560,808 		163,979 -10.1% 3.42 US$560,808
2025-08-22 2025-08-21 S Sale
5AM Partners VII, LLC
Large shareholder
2,314 -3.5%
3.57
US$8,261 		2,314 -3.5% 3.57 US$8,261
2025-08-22 2025-08-21 S Sale
5AM Partners VII, LLC
Large shareholder
58,642 -3.5%
3.57
US$209,352 		58,642 -3.5% 3.57 US$209,352
2025-08-22 2025-08-21 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
2,314 -3.5%
3.57
US$8,261 		2,314 -3.5% 3.57 US$8,261
2025-08-22 2025-08-21 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
58,642 -3.5%
3.57
US$209,352 		58,642 -3.5% 3.57 US$209,352
2024-11-20 2024-11-18 S Sale
Diep Tuan Tu

Chief Development Officer

Officer
19,489 -19.2%
4.99
US$97,250 		19,489 -19.2% 4.99 US$97,250
2024-11-19 2024-11-18 S Sale
ARSENAULT KAITLYN

Chief Financial Officer

Officer
43,206 -20.6%
4.99
US$215,598 		43,206 -20.6% 4.99 US$215,598
2024-11-19 2024-11-18 S Sale
DHILLON PUNIT

Chief Executive Officer

Executive Director
82,546 -20.0%
4.99
US$411,905 		82,546 -20.0% 4.99 US$411,905
2024-11-19 2024-11-18 S Sale
Grayson Paul A.
Non-Executive Director
86,244 -24.9%
4.99
US$430,358 		86,244 -24.9% 4.99 US$430,358
2024-11-20 2024-11-15 S Sale
Diep Tuan Tu

Chief Development Officer

Officer
85 -0.1%
5.55
US$472 		85 -0.1% 5.55 US$472
2024-11-19 2024-11-15 S Sale
ARSENAULT KAITLYN

Chief Financial Officer

Officer
190 -0.1%
5.55
US$1,054 		190 -0.1% 5.55 US$1,054
2024-11-19 2024-11-15 S Sale
DHILLON PUNIT

Chief Executive Officer

Executive Director
364 -0.1%
5.55
US$2,020 		364 -0.1% 5.55 US$2,020
2024-11-19 2024-11-15 S Sale
Grayson Paul A.
Non-Executive Director
307 -0.1%
5.55
US$1,704 		307 -0.1% 5.55 US$1,704
2024-11-15 2024-11-15 PrS Proposed sale
ARSENAULT KAITLYN

Officer

Officer
57,084
5.51
US$314,533 		57,084 5.51 US$314,533
2024-11-15 2024-11-15 PrS Proposed sale
DHILLON PUNIT

Officer; Director

Executive Director
100,693
5.51
US$554,818 		100,693 5.51 US$554,818
2024-11-15 2024-11-15 PrS Proposed sale
Diep Tuan Tu

Officer

Officer
22,877
5.51
US$126,052 		22,877 5.51 US$126,052
2024-11-15 2024-11-15 PrS Proposed sale
Grayson Paul A.

Director

Non-Executive Director
86,804
5.51
US$478,290 		86,804 5.51 US$478,290
2024-09-13 2024-09-13 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
79 -0.1%
6.06
US$479 		79 -0.1% 6.06 US$479
2024-09-13 2024-09-13 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
2,000 -0.1%
6.06
US$12,120 		2,000 -0.1% 6.06 US$12,120
2024-09-13 2024-09-13 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
11,758 -0.1%
6.06
US$71,253 		11,758 -0.1% 6.06 US$71,253
2024-09-13 2024-09-13 S Sale
5AM Partners VII, LLC
Large shareholder
79 -0.1%
6.06
US$479 		79 -0.1% 6.06 US$479
2024-09-13 2024-09-13 S Sale
5AM Partners VII, LLC
Large shareholder
2,000 -0.1%
6.06
US$12,120 		2,000 -0.1% 6.06 US$12,120
2024-09-13 2024-09-13 S Sale
5AM Partners VII, LLC
Large shareholder
11,758 -0.1%
6.06
US$71,253 		11,758 -0.1% 6.06 US$71,253
2024-09-13 2024-09-11 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
1,440 -2.1%
6.60
US$9,504 		1,440 -2.1% 6.60 US$9,504
2024-09-13 2024-09-11 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
36,504 -2.1%
6.60
US$240,926 		36,504 -2.1% 6.60 US$240,926
2024-09-13 2024-09-11 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
214,556 -2.6%
6.60
US$1,416,070 		214,556 -2.6% 6.60 US$1,416,070
2024-09-13 2024-09-11 S Sale
5AM Partners VII, LLC
Large shareholder
1,440 -2.1%
6.60
US$9,504 		1,440 -2.1% 6.60 US$9,504
2024-09-13 2024-09-11 S Sale
5AM Partners VII, LLC
Large shareholder
36,504 -2.1%
6.60
US$240,926 		36,504 -2.1% 6.60 US$240,926
2024-09-13 2024-09-11 S Sale
5AM Partners VII, LLC
Large shareholder
214,556 -2.6%
6.60
US$1,416,070 		214,556 -2.6% 6.60 US$1,416,070
2024-03-15 2024-03-13 B Purchase
5AM Partners VII, LLC
Large shareholder
450,000 +5.7%
10.00
US$4,500,000 		450,000 +5.7% 10.00 US$4,500,000
2024-02-02 2024-01-31 B Purchase
5AM Partners VII, LLC
Large shareholder
5,206,074 +190.2%
2.31
US$12,026,031 		5,206,074 +190.2% 2.31 US$12,026,031
2023-08-29 2023-08-29 B Purchase
DHILLON PUNIT

Chief Executive Officer

Executive Director
881,000 +2.2%
0.02
US$16,475 		881,000 +2.2% 0.02 US$16,475
2018-02-21 2018-02-16 B Purchase Emerald Health Sciences Inc. Large shareholder
15,000,000
0.00
US$0 		15,000,000 0.00 US$0
2015-04-10 2015-04-10 S Sale Ladin Brian D Large shareholder
11,830 -4.5%
4.93
US$58,310 		11,830 -4.5% 4.93 US$58,310
2015-04-10 2015-04-08 S Sale Ladin Brian D Large shareholder
15,800 -5.7%
4.79
US$75,682 		15,800 -5.7% 4.79 US$75,682
2015-04-10 2015-04-08 S Sale Ladin Brian D Large shareholder
23,000 -7.7%
4.69
US$107,893 		23,000 -7.7% 4.69 US$107,893
Explore more

More insider trading research around Emerald Bioscience Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America